Inventor
MARQUARDT TOBIAS
DE20 patents
⚠️ This page may combine multiple inventors who share the name “MARQUARDT TOBIAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
14 patentsUS11166932B2Nov 9, 2021
Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and/or an angiotensin AII antagonist and the use thereof
Bayer Pharma AG2 citations73
US9605008B2Mar 28, 2017
Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof
Bayer Pharma AG3 citations72
US9422285B2Aug 23, 2016
Substituted pyrazolo[1,5-A]-pyridine-3-carboxamides and use thereof
Bayer Pharma AG4 citations72
US10519154B2Dec 31, 2019
7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof
Bayer Pharma AG2 citations70
US10435403B2Oct 8, 2019
Positive allosteric modulators of muscarinic M2 receptor
Bayer Pharma AG7 citations70
US10150773B2Dec 11, 2018
N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases
Bayer Pharma AG3 citations70
US12427131B2Sep 30, 2025
Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and/or an angiotensin AII antagonist and the use thereof
Bayer Pharma AG0 citations62
US9688699B2Jun 27, 2017
3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
Bayer Pharma AG1 citations51
US10214526B2Feb 26, 2019
Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof
Bayer Pharma AG0 citations49
US10292970B2May 21, 2019
Heteroaryl-substituted imidazo[1,2-A]pyridines and their use
Bayer Pharma AG0 citations41
US10174021B2Jan 8, 2019
Substituted pyrazolo[1,5-A]pyridines and their use
Bayer Pharma AG0 citations41
US9771360B2Sep 26, 2017
Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use
Bayer Pharma AG0 citations41
US9714266B2Jul 25, 2017
Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3)
Bayer Pharma AG0 citations38
US9512169B2Dec 6, 2016
3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
Bayer Pharma AG0 citations38
BAYER AG
3 patentsUS11472803B2Oct 18, 2022
7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
BAYER AG0 citations59
US10927109B2Feb 23, 2021
7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
BAYER AG1 citations58
US12331094B2Jun 17, 2025
Atrial natriuretic peptide engrafted antibodies
BAYER AG0 citations45